Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Queensland Health
US Army
Harvard Business School
Merck
Colorcon

Generated: July 17, 2019

DrugPatentWatch Database Preview

Generic Companies with Tentative Approvals for: Akorn Inc

Try a free trialSee Plans and Pricing

« Back to Dashboard

Akorn Inc Generic Filers with Tentative Approvals

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Applicant Generic Name NDA Strength Dosage Form
Akorn Inc palonosetron hydrochloride 204731 0.25MG(BASE)/5ML INJECTABLE;INJECTION
Akorn Inc moxifloxacin 202916 0.5% SOLUTION; OPHTHALMIC
Akorn Inc timolol maleate 204912 0.5% SOLUTION;OPHTHALMIC
Applicant Generic Name NDA Strength Dosage Form

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
QuintilesIMS
Chinese Patent Office
Teva
Baxter
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.